Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Enforced effect of tk-MCP-1 fusion gene in ovarian cancer.

Hong S, Zhang P, Zhang H, Jia L, Qu X, Yang Q, Rong F, Kong B.

J Exp Clin Cancer Res. 2012 Sep 12;31:74. doi: 10.1186/1756-9966-31-74.

PMID:
22971726
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.

Tsuchiyama T, Kaneko S, Nakamoto Y, Sakai Y, Honda M, Mukaida N, Kobayashi K.

Cancer Gene Ther. 2003 Apr;10(4):260-9. Erratum in: Cancer Gene Ther. 2003 Aug;10(8):647.

PMID:
12679798
[PubMed - indexed for MEDLINE]
3.

Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.

Kagaya T, Nakamoto Y, Sakai Y, Tsuchiyama T, Yagita H, Mukaida N, Kaneko S.

Cancer Gene Ther. 2006 Apr;13(4):357-66.

PMID:
16224495
[PubMed - indexed for MEDLINE]
4.

Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.

Guan J, Ma L, Wei L.

Chin Med J (Engl). 2001 Feb;114(2):147-51.

PMID:
11780195
[PubMed - indexed for MEDLINE]
Free Article
5.

Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.

Sakai Y, Kaneko S, Nakamoto Y, Kagaya T, Mukaida N, Kobayashi K.

Cancer Gene Ther. 2001 Oct;8(10):695-704.

PMID:
11687892
[PubMed - indexed for MEDLINE]
Free Article
6.

Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.

Tang Q, Zhang D, Wan M, Jin L.

Cancer Biother Radiopharm. 2007 Dec;22(6):755-61.

PMID:
18158766
[PubMed - indexed for MEDLINE]
7.

In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.

Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.

J Gene Med. 2004 Mar;6(3):288-99.

PMID:
15026990
[PubMed - indexed for MEDLINE]
8.
9.

Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.

Azatian A, Yu H, Dai W, Schneiders FI, Botelho NK, Lord RV.

J Gastrointest Surg. 2009 Jun;13(6):1044-51. doi: 10.1007/s11605-009-0839-1. Epub 2009 Mar 10.

PMID:
19277794
[PubMed - indexed for MEDLINE]
10.
11.

Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric cancer.

Zhang JH, Wan MX, Pan BR, Yu B.

Cancer Biol Ther. 2004 Nov;3(11):1075-80. Epub 2004 Nov 12.

PMID:
15477756
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.

Hu WX, Zeng ZJ, Luo SQ, Chen Q.

Chin Med J (Engl). 2004 Mar;117(3):434-9.

PMID:
15043787
[PubMed - indexed for MEDLINE]
Free Article
14.

Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine.

Kang Y, Zhang X, Jiang W, Wu C, Chen C, Zheng Y, Gu J, Xu C.

BMC Cancer. 2009 Apr 27;9:126. doi: 10.1186/1471-2407-9-126.

PMID:
19397814
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.

Kong B, Wang W, Liu C, Song L, Ma D, Qu X, Jiang J, Yang X, Zhang Y, Wang B, Wei MQ, Yang Q.

In Vivo. 2003 Mar-Apr;17(2):153-6.

PMID:
12792977
[PubMed - indexed for MEDLINE]
16.

Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma.

Marukawa Y, Nakamoto Y, Kakinoki K, Tsuchiyama T, Iida N, Kagaya T, Sakai Y, Naito M, Mukaida N, Kaneko S.

Cancer Gene Ther. 2012 May;19(5):312-9. doi: 10.1038/cgt.2012.3. Epub 2012 Mar 9.

PMID:
22402625
[PubMed - indexed for MEDLINE]
17.

[Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter].

Song Y, Kong BH, Liu PS, Ma DX, Qu X, Jiang S.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Aug;25(4):438-42. Chinese.

PMID:
12974091
[PubMed - indexed for MEDLINE]
18.

[In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].

Kong BH, Song Y, Ma DX, Qu X, Jiang S.

Zhonghua Fu Chan Ke Za Zhi. 2004 Jun;39(6):390-5. Chinese.

PMID:
15312323
[PubMed - indexed for MEDLINE]
19.

Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.

Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.

Cancer Gene Ther. 2003 May;10(5):353-64.

PMID:
12719705
[PubMed - indexed for MEDLINE]
20.

[Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].

Kang Y, Xu CJ, Liu XS, Wu CQ, Zhong CP, Gu JR.

Ai Zheng. 2005 Aug;24(8):909-14. Chinese.

PMID:
16086864
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk